---
figid: PMC7933196__fcimb-10-588517-g001
figtitle: Berberine on diseases by regulating intestinal flora
organisms:
- NA
pmcid: PMC7933196
filename: fcimb-10-588517-g001.jpg
figlink: pmc/articles/PMC7933196/figure/f1/
number: F1
caption: 'Effects of berberine on diseases by regulating intestinal flora. 1. Berberine
  can activate TLR4/MyD88/NF-κB signal pathway to play an anti-inflammatory role,
  and increase the populations of Bacteroidetes, Clostridia, Lactobacillales, Prevotellaceae,
  Alloprevotella, Butyricimonas, Coprococcus, Ruminococcus, Lactobacillus, Akkermansia,
  Verrucomicrobia, reduce the populations of Bacteroidales, Lachnospiraceae, Rikenellaceae,
  Desulfovibrio, Streptococcaceae, Clostridiaceae, Prevotella, Proteus, Saccharibacteria,
  Deferribacteres, Actinobacteria, which affect the development of diabetes. 2. Berberine
  affects liver diseases by regulating FXR and NF-κB signaling pathways through intestinal
  flora. 3. Berberine down-regulate F:B (Firmicutes : Bacteroidetes) and up-regulate
  SCFA-producing bacteria Allobaculum, Bacteroides, Blautia, Butyricicoccus, Phascolarctobacterium,
  A. muciniphila and GLP-1R in obesity. 4. Berberine regulates hyperlipidemia by reducing
  Prevotella, Escherichia, Clostridium Sutterella and increase Bacteroides, Parabacteroides,
  Blautia, Enterobacter, Akkermansia, Escherichia-Shigella, Incertae sedis, Lachnospiraceae
  FCS020, Clostridium sensu stricto 1. 5. In Enteropatia, berberine enriched the relative
  abundance of Firmicutes and decreased Proteobacteria at the phylum level. Meanwhile,
  berberine increased the propotion of unclassified_f_Porphyromonadaceae, unclassified_f_Lachnospiraceae,
  Lactobacillus, unclassified_o_Clostridiales, Ruminococcus, Prevotella, Clostridium
  IV, and decreased Escherichia/Shigella at the genera level. 6. Berberine affect
  the development of Atherosclerosis by changing the amount of Verrucomicrobia, Akkermansia
  in Apoe (−/−) mice fed a high-fat diet in the intestine.'
papertitle: Effects of Berberine on the Gastrointestinal Microbiota.
reftext: Lichao Zhang, et al. Front Cell Infect Microbiol. 2020;10:588517.
year: '2020'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.8978451
figid_alias: PMC7933196__F1
figtype: Figure
organisms_ner:
- Homo sapiens
redirect_from: /figures/PMC7933196__F1
ndex: ''
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC7933196__fcimb-10-588517-g001.html
  '@type': Dataset
  description: 'Effects of berberine on diseases by regulating intestinal flora. 1.
    Berberine can activate TLR4/MyD88/NF-κB signal pathway to play an anti-inflammatory
    role, and increase the populations of Bacteroidetes, Clostridia, Lactobacillales,
    Prevotellaceae, Alloprevotella, Butyricimonas, Coprococcus, Ruminococcus, Lactobacillus,
    Akkermansia, Verrucomicrobia, reduce the populations of Bacteroidales, Lachnospiraceae,
    Rikenellaceae, Desulfovibrio, Streptococcaceae, Clostridiaceae, Prevotella, Proteus,
    Saccharibacteria, Deferribacteres, Actinobacteria, which affect the development
    of diabetes. 2. Berberine affects liver diseases by regulating FXR and NF-κB signaling
    pathways through intestinal flora. 3. Berberine down-regulate F:B (Firmicutes
    : Bacteroidetes) and up-regulate SCFA-producing bacteria Allobaculum, Bacteroides,
    Blautia, Butyricicoccus, Phascolarctobacterium, A. muciniphila and GLP-1R in obesity.
    4. Berberine regulates hyperlipidemia by reducing Prevotella, Escherichia, Clostridium
    Sutterella and increase Bacteroides, Parabacteroides, Blautia, Enterobacter, Akkermansia,
    Escherichia-Shigella, Incertae sedis, Lachnospiraceae FCS020, Clostridium sensu
    stricto 1. 5. In Enteropatia, berberine enriched the relative abundance of Firmicutes
    and decreased Proteobacteria at the phylum level. Meanwhile, berberine increased
    the propotion of unclassified_f_Porphyromonadaceae, unclassified_f_Lachnospiraceae,
    Lactobacillus, unclassified_o_Clostridiales, Ruminococcus, Prevotella, Clostridium
    IV, and decreased Escherichia/Shigella at the genera level. 6. Berberine affect
    the development of Atherosclerosis by changing the amount of Verrucomicrobia,
    Akkermansia in Apoe (−/−) mice fed a high-fat diet in the intestine.'
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - MYD88
  - TLR4
  - HM13
  - NR1H4
  - NFKB1
  - FUT1
  - CD36
  - CD14
  - NDUFA2
  - Berberine
  - Rikenellacene
  - Prevotellacene
  - Porphyromonadacene
  - TCA
  - Atherosclerosis
  - Clostridia
  - ODiabetes
  - Hyperlipidemia
---
